Inhibitor | ML-9, Hydrochloride  

Compound name Brutto MW CAS PubChem CID Action Reference Reference
ML-9, Hydrochloride   C15H17ClN2O2S • HCl 361.30 105637-50-1 108047 MLCK Reig J.A. (1993) Neurochem. Res. 18 317 Nagatsu T. (1987) Biochem. Biophys. Res. Commun. 143 1045

Screening Results Chart

Screening Results Tables

Screen Conc: 10.00µM
Kinase % Activity Remaining Standard Deviation
AMPK 85 14
Aurora B 63 2
CAMK1 74 8
CDK2-Cyclin A 57 2
CHK1 86 5
CHK2 77 5
CK1 delta 91 3
CK2 78 4
CSK 80 8
DYRK1A 84 16
EF2K 88 12
ERK2 96 7
ERK8 84 10
GSK3 beta 80 5
IKK beta 71 1
JNK1 84 9
JNK3 76 1
Lck 75 0
MAPKAP-K2 85 4
MAPKAP-K3 97 6
MARK3 103 5
MKK1 58 14
MNK1 66 0
MNK2 81 9
MSK1 30 1
MST2 82 0
NEK2a 83 0
NEK6 103 14
NEK7 92 8
p38 alpha MAPK 88 3
p38 beta MAPK 80 4
p38 delta MAPK 65 13
p38 gamma MAPK 91 4
PDK1 96 7
PHK 95 5
PIM2 63 0
PKA 61 3
PKB alpha 89 5
PKB beta 92 4
PKC alpha 72 2
PKD1 85 8
PLK1 101 6
PRAK 77 1
PRK2 15 0
ROCK 2 28 0
RSK1 43 8
RSK2 67 6
S6K1 32 6
SGK1 82 11
SmMLCK 95 40
Src 82 3
SRPK1 87 16
Screen Conc: 100.00µM
Kinase % Activity Remaining Standard Deviation
AMPK 32 3
Aurora B 57 2
Aurora C 73 3
BRSK2
2
5
CAMK1 17 3
CAMKK alpha 108 1
CAMKK beta 75 1
CDK2-Cyclin A 13 1
CHK1 94 2
CHK2 108 5
CK1 delta 58 3
CK2 25 2
CSK 78 2
DYRK1A 46 5
DYRK2 79 6
DYRK3 30 2
EF2K 122 1
ERK1 91 1
ERK2 91 8
ERK8 50 2
GSK3 beta 88 1
HIPK2 43 1
HIPK3 68 5
IKK beta 67 1
JNK1 115 1
JNK2 92 4
JNK3 92 0
Lck 81 1
MAPKAP-K2 69 4
MAPKAP-K3 79 2
MARK3 130 1
MELK 66 7
MKK1 75 3
MNK1 28 4
MNK2 40 2
MSK1 11 3
MST2 74 4
NEK2a 94 3
NEK6 105 1
NEK7 122 6
p38 alpha MAPK 92 6
p38 beta MAPK 86 1
p38 delta MAPK 88 4
p38 gamma MAPK 87 4
PAK4 94 1
PAK5 85 4
PAK6 108 4
PDK1 87 2
PHK 47 6
PIM1
7
0
PIM2 43 6
PIM3
7
0
PKA 25 5
PKB alpha 44 4
PKB beta 58 3
PKC alpha 27 0
PKC zeta 50 5
PKD1 48 5
PLK1 98 7
PRAK 37 6
PRK2
1
1
ROCK 2
6
0
RSK1 12 0
RSK2 19 1
S6K1 13 1
SGK1 59 4
SmMLCK 31 0
Src 100 1
SRPK1 92 1